These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
251 related articles for article (PubMed ID: 11833195)
1. Mixed WTO ruling on generic drug development. Elliott R Can HIV AIDS Policy Law Newsl; 2000; 5(2-3):38-42, 40-4. PubMed ID: 11833195 [TBL] [Abstract][Full Text] [Related]
2. Canada ordered to implement WTO ruling against "stockpiling" of generic drugs. Elliott R Can HIV AIDS Policy Law Rev; 2000; 5(4):27. PubMed ID: 11833161 [TBL] [Abstract][Full Text] [Related]
3. Canada loses appeal of WTO panel ruling on minimum patent terms. Elliott R Can HIV AIDS Policy Law Rev; 2000; 5(4):25-6. PubMed ID: 11833160 [TBL] [Abstract][Full Text] [Related]
4. Bill C-30: who wins and who loses in Canada's pharmaceutical patent battles? Hollis A Expert Opin Ther Pat; 2018 Jan; 28(1):1-3. PubMed ID: 28974123 [No Abstract] [Full Text] [Related]
5. Steps forward, backward, and sideways: Canada's bill on exporting generic pharmaceuticals. Elliott R HIV AIDS Policy Law Rev; 2004 Dec; 9(3):15-21. PubMed ID: 15801105 [TBL] [Abstract][Full Text] [Related]
6. Canada to change patent law to allow export of cheap drugs. Kondro W Lancet; 2003 Oct; 362(9392):1290. PubMed ID: 14577437 [No Abstract] [Full Text] [Related]
7. TRIPS from Doha to Cancún ... to Ottawa: global developments in access to treatment and Canada's Bill C-56. Elliott R Can HIV AIDS Policy Law Rev; 2003 Dec; 8(3):1, 7-18. PubMed ID: 15104062 [TBL] [Abstract][Full Text] [Related]
8. A one-time-only combination: Emergency medicine exports and the TRIPS agreement under Canada's access to medicines regime. Weber A; Mills L Health Hum Rights; 2010 Jun; 12(1):109-22. PubMed ID: 20930258 [TBL] [Abstract][Full Text] [Related]
9. Panel rules against Canada on patent terms for pre-TRIPS patents. Elliott R Can HIV AIDS Policy Law Newsl; 2000; 5(2-3):43, 45. PubMed ID: 11833196 [TBL] [Abstract][Full Text] [Related]
10. International trade regulation and publicly funded health care in Canada. Ostry AS Int J Health Serv; 2001; 31(3):475-80. PubMed ID: 11562000 [TBL] [Abstract][Full Text] [Related]
11. First test of WTO mechanism for procuring generic medicines under compulsory licence, via Canada's Access to Medicines Regime. Elliott R HIV AIDS Policy Law Rev; 2007 Dec; 12(2-3):23-5. PubMed ID: 18459195 [TBL] [Abstract][Full Text] [Related]
12. The Eleventh Circuit holds that agreements in which pharmaceutical companies pay generic companies not to compete may be valid. Garrigues A J Law Med Ethics; 2004; 32(1):181-4. PubMed ID: 15152443 [No Abstract] [Full Text] [Related]
13. Will they deliver treatment access?: WTO rules and Canada's law on generic medicine exports. Elliott R HIV AIDS Policy Law Rev; 2006 Dec; 11(2-3):13-6. PubMed ID: 17373059 [TBL] [Abstract][Full Text] [Related]
14. The new patent regime and disease priorities in India. Gupta I; Guin P; Trivedi M Glob Public Health; 2013; 8(1):37-54. PubMed ID: 22845021 [TBL] [Abstract][Full Text] [Related]
15. The WTO dispute settlement understanding: an unlikely weapon in the fight against AIDS. Curti AM Am J Law Med; 2001; 27(4):469-85. PubMed ID: 11837145 [No Abstract] [Full Text] [Related]
16. Asserting the primacy of health over patent rights: a comparative study of the processes that led to the use of compulsory licensing in Thailand and Brazil. Rosenberg ST Dev World Bioeth; 2014 Aug; 14(2):83-91. PubMed ID: 24750542 [TBL] [Abstract][Full Text] [Related]
17. Why are generic drugs being held up in transit? Intellectual property rights, international trade, and the right to health in Brazil and beyond. Rosina MS; Shaver L J Law Med Ethics; 2012; 40(2):197-205. PubMed ID: 22789040 [TBL] [Abstract][Full Text] [Related]
18. US files WTO complaints against Brazil over requirement for "local working" of patents. Elliott R Can HIV AIDS Policy Law Rev; 2000; 5(4):28. PubMed ID: 11833162 [TBL] [Abstract][Full Text] [Related]
19. Affordable antiretroviral drugs for the under-served markets: how to expand equitable access against the backdrop of challenging scenarios? Dionisio D; Cao Y; Hongzhou L; Kraisintu K; Messeri D Curr HIV Res; 2006 Jan; 4(1):3-20. PubMed ID: 16454707 [TBL] [Abstract][Full Text] [Related]
20. Has the implementation of the TRIPS Agreement in Latin America and the Caribbean produced intellectual property legislation that favours public health? Oliveira MA; Bermudez JA; Chaves GC; Velásquez G Bull World Health Organ; 2004 Nov; 82(11):815-21. PubMed ID: 15640916 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]